Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

Articles published in
Gene
    March 2025
  1. HSU CY, Rab SO, Zwamel AH, Oghenemaro EF, et al
    From diagnosis to therapy: The role of LncRNA GAS5 in combatting some cancers affecting women.
    Gene. 2025;941:149217.
    >> Share

    February 2025
  2. KAZAN HH, Acinan IS, Kandemir B, Karahan CP, et al
    Copy number variations of stepwise-selected doxorubicin-resistant MCF-7 cell lines.
    Gene. 2025;937:149139.
    >> Share

    January 2025
  3. DU S, Liu J, Ning Y, Yin M, et al
    The piR-31115-PIWIL4 complex promotes the migration of the triple-negative breast cancer cell lineMDA-MB-231 by suppressing HSP90AA1 degradation.
    Gene. 2025 Jan 20:149255. doi: 10.1016/j.gene.2025.149255.
    >> Share

  4. WANG G, Wang J, Li C, Mu X, et al
    ZNF703 promotes Triple-Negative breast cancer cell progression and in combination with STK11 predicts disease recurrence (ZS -TNBC Model).
    Gene. 2025;942:149258.
    >> Share

  5. STIPP MC, Acco A
    c-Myc-targeted therapy in breast cancer: A review of fundamentals and pharmacological Insights.
    Gene. 2025 Jan 2:149209. doi: 10.1016/j.gene.2024.149209.
    >> Share

    December 2024
  6. WANG Y, Zhang J, Wang Y, Liu Y, et al
    Lower expression of MMP2, FLNA, and CFL1 is correlated with favorable prognosis in invasive micropapillary breast cancer.
    Gene. 2024 Dec 24:149192. doi: 10.1016/j.gene.2024.149192.
    >> Share

    November 2024
  7. LI Y, Gao H
    Investigation and validation of neurotransmitter receptor-related biomarkers for forecasting clinical outcomes and immunotherapeutic efficacy in breast cancer.
    Gene. 2024;937:149135.
    >> Share

  8. NIAZMAND A, Nedaeinia R, Vatandoost N, Jafarpour S, et al
    The impacts of dipeptidyl- peptidase 4 (DPP-4) inhibitors on common female malignancies: A systematic review.
    Gene. 2024;927:148659.
    >> Share

    October 2024
  9. TAN SY, Foo CN, Ng FL, Tan CH, et al
    Gene expression Profiling of maslinic Acid-treated MCF-7 breast cancer cells using Nanostring nCounter Pancancer pathway Panel.
    Gene. 2024 Oct 30:149043. doi: 10.1016/j.gene.2024.149043.
    >> Share

  10. CHEN S, Liu M, Yi W, Li H, et al
    Micropeptides derived from long non-coding RNAs: Computational analysis and functional roles in breast cancer and other diseases.
    Gene. 2024 Oct 24:149019. doi: 10.1016/j.gene.2024.149019.
    >> Share

  11. KONG L, Jin X
    Corrigendum to "Dysregulation of deubiquitination in breast cancer" [Gene (2024) 148175].
    Gene. 2024 Oct 24:149023. doi: 10.1016/j.gene.2024.149023.
    >> Share

  12. WEN P, Jiang D, Qu F, Wang G, et al
    PFDN5 plays a dual role in breast cancer and regulates tumor immune microenvironment: Insights from integrated bioinformatics analysis and experimental validation.
    Gene. 2024;933:149000.
    >> Share

    August 2024
  13. DAI P, Chen Y, Zhang X, Liu L, et al
    MRPL13 is a metastatic and prognostic marker of breast cancer: A silico analysis accompanied with experimental validation.
    Gene. 2024;932:148908.
    >> Share

  14. HE X, Huang H, Liu Y, Li H, et al
    Analysis of the function, mechanism and clinical application prospect of TRPS1, a new marker for breast cancer.
    Gene. 2024 Aug 22:148880. doi: 10.1016/j.gene.2024.148880.
    >> Share

  15. LAKSHMI S, Priya S
    Molecular insights into epoxyazadiradione induced death in triple-negative breast cancer cells: A system biology approach.
    Gene. 2024 Aug 6:148814. doi: 10.1016/j.gene.2024.148814.
    >> Share

    July 2024
  16. GHALI RM, Zaied S, Daldoul A, Kanabekova P, et al
    Association between Toll-like receptor 2 rs4696483 and rs1898830 polymorphisms and the risk of triple-negative breast cancer.
    Gene. 2024 Jul 17:148773. doi: 10.1016/j.gene.2024.148773.
    >> Share

  17. ABDULLAH AR, Gamal El-Din AM, Ismail Y, El-Husseiny AA, et al
    The FSCN1 gene rs2966447 variant is associated with increased serum fascin-1 levels and breast cancer susceptibility.
    Gene. 2024 Jul 2:148743. doi: 10.1016/j.gene.2024.148743.
    >> Share

    June 2024
  18. ALOUFI A, Aubee J, Vargas KM, Apprey V, et al
    Vitamin D receptor polymorphisms and associated miRNAs in the development of breast cancer in African American women.
    Gene. 2024 Jun 28:148695. doi: 10.1016/j.gene.2024.148695.
    >> Share

  19. VOSOOGHI R, Motavalizadehkakhky A, Mansouri A, Mehrzad J, et al
    Investigating the effect of hesperetin on estrogen receptor alpha (ERalpha) expression, phosphorylation and activity in MCF-7 cells.
    Gene. 2024;911:148357.
    >> Share

    April 2024
  20. DEHGHANIAN F, Ghahnavieh LE, Nilchi AN, Khalilian S, et al
    Breast cancer drug resistance: Decoding the roles of Hippo pathway crosstalk.
    Gene. 2024;916:148424.
    >> Share

    March 2024
  21. QI Q, Zhu M, Li P, Mi Q, et al
    Systematic analysis of PANoptosis-related genes identifies XIAP as a functional oncogene in breast cancer.
    Gene. 2024 Mar 9:148355. doi: 10.1016/j.gene.2024.148355.
    >> Share

  22. YANG Y, Li W, Yang H, Zhang Y, et al
    Research progress on the regulatory mechanisms of FOXC1 expression in cancers and its role in drug resistance.
    Gene. 2024;897:148079.
    >> Share

    January 2024
  23. KONG L, Jin X
    Dysregulation of deubiquitination in breast cancer.
    Gene. 2024 Jan 17:148175. doi: 10.1016/j.gene.2024.148175.
    >> Share

  24. WASSON MD, Venkatesh J, Cahill HF, McLean ME, et al
    LncRNAs exhibit subtype-specific expression, survival associations, and cancer-promoting effects in breast cancer.
    Gene. 2024 Jan 12:148165. doi: 10.1016/j.gene.2024.148165.
    >> Share

    November 2023
  25. HOSSEINKHANI N, Hemmat N, Baghbani E, Baghbanzadeh A, et al
    Dual silencing of tumor-intrinsic VISTA and CTLA-4 stimulates T-cell mediated immune responses and inhibits MCF7 breast cancer development.
    Gene. 2023;896:148043.
    >> Share

  26. YANG B, Wang YW, Zhang K
    Interactions between circRNA and protein in breast cancer.
    Gene. 2023;895:148019.
    >> Share

  27. SINGH A, Thomas Georgy J, Dhananjayan S, Sigamani E, et al
    Comparative Analysis of Mutational Patterns in Triple Negative Breast Cancer Before and after Neoadjuvant Chemotherapy in Patients with Residual Disease.
    Gene. 2023 Nov 9:147980. doi: 10.1016/j.gene.2023.147980.
    >> Share

    July 2023
  28. JIA Z, Huang Y, Liu J, Liu G, et al
    Single Nucleotide Polymorphisms Associated with Female Breast cancer Susceptibility in Chinese Population.
    Gene. 2023 Jul 29:147676. doi: 10.1016/j.gene.2023.147676.
    >> Share

  29. HATWIK J, Patil HN, Limaye AM
    Proliferative response of ERalpha-positive breast cancer cells to 10 muM enterolactone, and the associated alteration in the transcriptomic landscape.
    Gene. 2023 Jul 13:147640. doi: 10.1016/j.gene.2023.147640.
    >> Share

  30. YADAV P, Bandyopadhayaya S, Soni S, Saini S, et al
    Simvastatin prevents BMP-2 driven cell migration and invasion by suppressing oncogenic DNMT1 expression in breast cancer cells.
    Gene. 2023 Jul 11:147636. doi: 10.1016/j.gene.2023.147636.
    >> Share

    June 2023
  31. PAL U, Manjegowda MC, Singh N, Saikia S, et al
    The G-protein-coupled estrogen receptor, a gene co-expressed with ERalpha in breast tumors, is regulated by estrogen-ERalpha signalling in ERalpha positive breast cancer cells.
    Gene. 2023 Jun 4:147548. doi: 10.1016/j.gene.2023.147548.
    >> Share

    May 2023
  32. GHULE PN, Boyd JR, Kabala F, Fritz AJ, et al
    Corrigendum to "Spatiotemporal higher-order chromatin landscape of human histone gene clusters at histone locus bodies during the cell cycle in breast cancer progression" [Gene 872 (2023) 147441].
    Gene. 2023;873:147469.
    >> Share

    April 2023
  33. ANDREIS TF, de Souza KIW, Vieira IA, Alemar B, et al
    Challenges in periodic revision of genetic testing results: Comparison of the main classification guidelines and report of a retrospective analysis involving BRCA1/BRCA2 variants of uncertain significance.
    Gene. 2023;862:147281.
    >> Share

  34. GHULE PN, Boyd JR, Kabala F, Fritz AJ, et al
    Spatiotemporal higher-order chromatin landscape of human histone gene clusters at Histone Locus Bodies during the cell cycle in breast cancer progression.
    Gene. 2023 Apr 22:147441. doi: 10.1016/j.gene.2023.147441.
    >> Share

  35. HAMADEH LN, Farhat L, Hilal L, Assi H, et al
    Frequency and Mutational Spectrum of PIK3CA gene mutations in Breast Cancer Patients: Largest and First Report from Lebanon.
    Gene. 2023 Apr 15:147433. doi: 10.1016/j.gene.2023.147433.
    >> Share

    February 2023
  36. WAGHELA BN, Pandit RJ, Puvar A, Shah FD, et al
    Identification of novel exonic variants contributing to hereditary breast and ovarian cancer in west Indian population.
    Gene. 2023;852:147070.
    >> Share

    January 2023
  37. LIN Q, Jiang Y, Zhou F, Zhang Y, et al
    Fatty acid synthase (FASN) inhibits the cervical squamous cell carcinoma (CESC) progression through the Akt/mTOR signaling pathway.
    Gene. 2023;851:147023.
    >> Share

  38. WEI X, Tao S, Mao H, Zhu H, et al
    Exosomal lncRNA NEAT1 induces paclitaxel resistance in breast cancer cells and promotes cell migration by targeting miR-133b.
    Gene. 2023 Jan 27:147230. doi: 10.1016/j.gene.2023.147230.
    >> Share

  39. HE Y, Xiao B, Lei T, Xuan J, et al
    LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer.
    Gene. 2023;860:147227.
    >> Share

  40. VOUTSADAKIS IA
    Breast cancer sub-types display heterogeneity in gene amplification and mRNA expression of the anti-apoptotic members of BCL2 family.
    Gene. 2023;857:147179.
    >> Share

  41. OUYANG Y, Lu W, Wang Y, Wang B, et al
    Integrated analysis of mRNA and extrachromosomal circular DNA profiles to identify thepotential mRNA biomarkers in breast cancer.
    Gene. 2023 Jan 7:147174. doi: 10.1016/j.gene.2023.147174.
    >> Share

    December 2022
  42. YUAN B, Dai Z, Liu G, Xie F, et al
    Novel RNA N6-methyladenosine regulator related signature for predicting clinical and immunological characteristics in breast cancer.
    Gene. 2022 Dec 1:147095. doi: 10.1016/j.gene.2022.147095.
    >> Share

    November 2022
  43. INTABLI H, Gee J, Oesterreich S, Yeoman MS, et al
    Glucocorticoid induced loss of oestrogen receptor alpha gene methylation and restoration of sensitivity to fulvestrant in triple negative breast cancer.
    Gene. 2022 Nov 5:147022. doi: 10.1016/j.gene.2022.147022.
    >> Share

    October 2022
  44. TARAN Z, Yektaniroumand Digehsaraei S, Salouti M, Amini B, et al
    Methotrexate loaded in alginate beads for controlled drug release against breast cancer.
    Gene. 2022;851:146941.
    >> Share

  45. SGHAIER I, Zidi S, El-Ghali RM, Daldoul A, et al
    Unique ESR1 and ESR2 estrogen receptor gene variants associated with altered risk of triple-negative breast cancer: a case-control study.
    Gene. 2022 Oct 16:146969. doi: 10.1016/j.gene.2022.146969.
    >> Share

  46. KUMAR U, Castellanos-Uribe M, May ST, Yague E, et al
    Adaptive resistance is not responsible for long-term drug resistance in a cellular model of triple negative breast cancer.
    Gene. 2022 Oct 1:146930. doi: 10.1016/j.gene.2022.146930.
    >> Share

    September 2022
  47. VOUTSADAKIS IA
    Molecular alterations in anti-apoptotic BCL2 family proteins in breast cancer cell line models, drug sensitivities and dependencies to guide the development of BCL2 inhibitors.
    Gene. 2022 Sep 10:146881. doi: 10.1016/j.gene.2022.146881.
    >> Share

    May 2022
  48. MALCOLM JR, Leese NK, Lamond-Warner PI, Brackenbury WJ, et al
    Widespread association of ERalpha with RMRP and tRNA genes in MCF-7 cells and breast cancers.
    Gene. 2022;821:146280.
    >> Share

    April 2022
  49. BHATT G, Gupta A, Rangan L, Mukund Limaye A, et al
    Global transcriptome analysis reveals partial estrogen-like effects of karanjin in MCF-7 breast cancer cells.
    Gene. 2022 Apr 18:146507. doi: 10.1016/j.gene.2022.146507.
    >> Share

  50. AN G, Feng L, Hou L, Li X, et al
    A bioinformatics analysis of zinc finger protein family reveals potential oncogenic biomarkers in breast cancer.
    Gene. 2022 Apr 1:146471. doi: 10.1016/j.gene.2022.146471.
    >> Share

    March 2022
  51. LOPEZ C, Barnon MT, Beacon TH, Nardocci G, et al
    The key role of differential broad H3K4me3 and H3K4ac domains in breast cancer.
    Gene. 2022;826:146463.
    >> Share

  52. GULL S, Farooq K, Tayyeb A, Imran Arshad M, et al
    Ethanolic extracts of Pakistani Euphorbiaceous plants induce apoptosis in breast cancer cells through induction of DNA damage and caspase-dependent pathway.
    Gene. 2022 Mar 8:146401. doi: 10.1016/j.gene.2022.146401.
    >> Share

    February 2022
  53. PREETHIKA A, Sonkusare S, Suchetha Kumari N
    Single Nucleotide Polymorphism of Fatty Acid Desaturase Gene and Breast Cancer Risk in Estrogen Receptor Subtype.
    Gene. 2022 Feb 16:146330. doi: 10.1016/j.gene.2022.146330.
    >> Share

  54. JAFARINEJAD-FARSANGI S, Moazzam-Jazi M, Naderi Ghale-Noie Z, Askari N, et al
    Investigation of genes and pathways involved in breast cancer subtypes through gene expression meta-analysis.
    Gene. 2022;821:146328.
    >> Share

  55. MORALES F, Perez P, Tapia JC, Lobos-Gonzalez L, et al
    Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells.
    Gene. 2022;819:146246.
    >> Share

    January 2022
  56. HEGDE M, Devi Daimary U, Kumar A, Chinnathambi A, et al
    STAT3/HIF1A and EMT specific transcription factors regulated genes: Novel predictors of breast cancer metastasis.
    Gene. 2022 Jan 21:146245. doi: 10.1016/j.gene.2022.146245.
    >> Share

  57. JABBARZADEH KABOLI P, Luo S, Chen Y, Jomhori M, et al
    Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress.
    Gene. 2022 Jan 10:146171. doi: 10.1016/j.gene.2021.146171.
    >> Share

    December 2021
  58. HUO X, Shen G, Li J, Wang M, et al
    Identification of the GTPase IMAP family as an immune-related prognostic biomarker in the breast cancer tumor microenvironment.
    Gene. 2021;812:146094.
    >> Share

  59. ZHU YY, Zhao YC, Chen C, Xie M, et al
    CCL5 secreted by luminal B breast cancer cells induces polarization of M2 macrophages through activation of MEK/STAT3 signaling pathway via CCR5.
    Gene. 2021 Dec 2:146100. doi: 10.1016/j.gene.2021.146100.
    >> Share

    October 2021
  60. KAUR B, Mukhlis Y, Natesh J, Penta D, et al
    Identification of hub genes associated with EMT-induced chemoresistance in breast cancer using integrated bioinformatics analysis.
    Gene. 2021 Oct 13:146016. doi: 10.1016/j.gene.2021.146016.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016